Inspire Medical Systems Q2 EPS $(0.41) Beats $(0.51) Estimate, Sales $151.09M Beat $137.66M Estimate
Portfolio Pulse from bharat@benzinga.com
Inspire Medical Systems (NYSE:INSP) reported Q2 losses of $(0.41) per share, beating the analyst consensus estimate of $(0.51) by 19.61%. The company also reported quarterly sales of $151.09 million, beating the analyst consensus estimate of $137.66 million by 9.76%. This represents a 22.64% increase in losses and a 65.33% increase in sales compared to the same period last year.
August 04, 2023 | 10:19 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inspire Medical Systems reported better than expected Q2 results, with both EPS and sales beating estimates. This could potentially lead to a positive market reaction.
Inspire Medical Systems reported better than expected Q2 results, with both EPS and sales beating estimates. This is generally seen as a positive signal by the market and could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100